iHear Medical said today it closed a $4.1 million Series C-2 round of financing, with funds slated to support the upscaling of manufacturing and distribution of its hearing products.
The round was led by San Leandro, Calif.-based iHear Medical’s marketing and distribution partner Ameritas, and joined by Aphelion Capital and Lighthouse Capital.
“We are excited to complete this round with this diverse and distinguished group of investors, and look forward to significant expansion and growth in 2017 and beyond,” founder & CEO Adnan Shennib said in a press release.
iHear said it launched its web-enabled hearing devices in the US in July last year, and plans to launch the devices in China in the 4th quarter of 2017.
The company produces the iHearHD and iHearMax connected hearing aids, as well as the FDA-cleared iHearTest home hearing screener.
The new round of financing will help support the company as it scales up manufacturing and distribution of the devices, as well as supporting development of next-gen wireless products which will feature novel internet of things capabilities.